Drug Profile
HIV vaccine vCP1452
Alternative Names: ALVAC-HIV vCP1452; vCP1452Latest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 02 Aug 2007 Discontinued - Phase-I/II for HIV-1 infections in USA (IM)
- 02 Aug 2007 Discontinued - Phase-II for HIV-1 infections in Brazil (IM)
- 02 Aug 2007 Discontinued - Phase-II for HIV-1 infections in European Union (IM)